Cargando…
Transgenic goats producing an improved version of cetuximab in milk
Therapeutic monoclonal antibodies (mAbs) represent one of the most important classes of pharmaceutical proteins to treat human diseases. Most are produced in cultured mammalian cells which is expensive, limiting their availability. Goats, striking a good balance between a relatively short generation...
Autores principales: | Laible, Götz, Cole, Sally, Brophy, Brigid, Maclean, Paul, How Chen, Li, Pollock, Dan P., Cavacini, Lisa, Fournier, Nathalie, De Romeuf, Christophe, Masiello, Nicholas C., Gavin, William G., Wells, David N., Meade, Harry M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655094/ https://www.ncbi.nlm.nih.gov/pubmed/33205005 http://dx.doi.org/10.1096/fba.2020-00059 |
Ejemplares similares
-
Cetuximab produced from a goat mammary gland expression system is equally efficacious as innovator cetuximab in animal cancer models
por: Wang, Qian, et al.
Publicado: (2020) -
Increased gene dosage for β- and κ-casein in transgenic cattle improves milk composition through complex effects
por: Laible, Götz, et al.
Publicado: (2016) -
Cattle with a precise, zygote-mediated deletion safely eliminate the major milk allergen beta-lactoglobulin
por: Wei, Jingwei, et al.
Publicado: (2018) -
Primary Transgenic Bovine Cells and Their Rejuvenated Cloned Equivalents Show Transgene-Specific Epigenetic Differences
por: Alonso-González, Lucia, et al.
Publicado: (2012) -
The genomes of precision edited cloned calves show no evidence for off-target events or increased de novo mutagenesis
por: Jivanji, Swati, et al.
Publicado: (2021)